Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2)
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-10-05 10:09:42 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-8587(25)00196-2
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858725001962
其他信息:
出版社: Elsevier BV
作者: Yang He; Nianrong Mi; Zhifeng Cheng; Haibo Xue; Jie Han; Haifang Wang; Huihui Wang; Jun Wu; Xiaoguang Shi; Shuping Zhao; Binhong Duan; Yikun Zhu; Yanqin Zhou; Feng Li; Xin Wang; Hongwei Ling; Su Wang; Qingju Li; Feifei Jiang; Ming Yang; Shaohui Bing; Qing Zheng; Jing Ning; Mengying Guo; Yue Bu; Lei Guan; Yao Li; Liu Yang; Wanjun Guo; Hai Pan; Xiaoying Li
